Helse Pharmaceuticals Private Limited
About Helse Pharmaceuticals Private Limited
Data last updated:
Helse Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 03 November 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U33111TG2015PTC101467. Its GSTIN is 36AADCH7405G1ZQ (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Vijay Rama Manneri Sreenivasa Raidu and Nagaraja Kumari Movva.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2020, the company reported a revenue of ₹64.1 Lakh, a growth of 90% compared to the previous year. For the same year it recorded a net profit of ₹1.62 Lakh (net margin 2.5%) and EBITDA of ₹2.28 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Helse Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Social Media
- Registered AddressLig – 928 H.No.15 – 27 – 928 Ground And 1st Floor Lig Phase 1 Near Maharastra Bank Kphb, Colony, Hyderabad, Telangana, India – 500072
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Helse Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Helse Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Helse Pharmaceuticals Private Limited, buy the company report.
Financials of Helse Pharmaceuticals Private Limited
FY 2024 filings availableHelse Pharmaceuticals Private Limited reported revenue of ₹64.1 Lakh (up 90% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over three years, including 90% growth in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹64.1 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.28 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.62 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Helse Pharmaceuticals Private Limited, buy the company report.
Board of directors of Helse Pharmaceuticals Private Limited
Helse Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Rama Manneri Sreenivasa Raidu Also directs: Fresco Marketing Private Limited | Additional Director | 20 May 2022 | 4 Years 5 Months | Current |
| Nagaraja Kumari Movva Also directs: Pradhi Exim International Private Limited | Additional Director | 02 Nov 2017 | 8 Years 11 Months | Current |
Auditor
Helse Pharmaceuticals Private Limited is audited by ALLURI & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ALLURI & CO | FY 2020 | 013605S |
Shareholding
The shareholding of Helse Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Helse Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Helse Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Helse Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Helse Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 04, 2024.
GST
Helse Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCH7405G1ZQ | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Helse Pharmaceuticals Private Limited, buy the company report.
Recent activity
Helse Pharmaceuticals Private Limited has 7 board changes on record since 2016: 2 appointments and 5 cessations. The latest: Sai Prasanthi Kodali ceased to be Managing Director on 28 May 2022.
Frequently asked questions
Helse Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 03 November 2015 (11+ years old) and is registered under CIN U33111TG2015PTC101467.
Helse Pharmaceuticals has 2 current directors:
- Vijay Rama Manneri Sreenivasa Raidu - Additional Director
- Nagaraja Kumari Movva - Additional Director
The latest financial statements of Helse Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Helse Pharmaceuticals is 36AADCH7405G1ZQ, registered in Telangana.
The CIN (Corporate Identification Number) of Helse Pharmaceuticals is U33111TG2015PTC101467. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Helse Pharmaceuticals was incorporated on 03 November 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sai Prasanthi Kodali ceased to be Managing Director on 28 May 2022. Vijay Rama Manneri Sreenivasa Raidu was appointed as Additional Director on 20 May 2022. Mandadapu Sudhakararao ceased to be Director on 03 May 2022. Helse Pharmaceuticals has 7 board changes on record in total.
The registered office of Helse Pharmaceuticals is at Lig – 928 H.No.15 – 27 – 928 Ground And 1st Floor Lig Phase 1 Near Maharastra Bank Kphb, Colony, Hyderabad, Telangana, India – 500072.
Helse Pharmaceuticals operates in the healthcare industry, in the preventive health services segment.
The compliance status of Helse Pharmaceuticals is compliant as of 21 July 2026. The company is actively filing with the Registrar of Companies.